ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 4 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $741,000 | -10.7% | 57 | 0.0% | 0.03% | -44.0% |
| Q3 2020 | $830,000 | -15.3% | 57 | -36.7% | 0.05% | -38.3% |
| Q1 2020 | $980,000 | -29.6% | 90 | -53.1% | 0.08% | -36.2% |
| Q2 2019 | $1,393,000 | -51.3% | 192 | -37.3% | 0.13% | -54.2% |
| Q1 2019 | $2,859,000 | +85.9% | 306 | +45.0% | 0.28% | +23.7% |
| Q4 2018 | $1,538,000 | +45.9% | 211 | +97.2% | 0.22% | +143.5% |
| Q2 2018 | $1,054,000 | – | 107 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 50,000 | $7,293,000 | 0.42% |
| GROUP ONE TRADING, L.P. | 160,100 | $23,351,000 | 0.04% |
| JANE STREET GROUP, LLC | 271,600 | $39,613,000 | 0.02% |
| SIMPLEX TRADING, LLC | 20,600 | $3,004,000 | 0.00% |
| Twin Tree Management, LP | 3,600 | $525,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 11,900 | $1,736,000 | 0.00% |